Opening of the Radspherin ® Production and Laboratory Facility
Oncoinvent held an opening ceremony for its new production and lab facilities today. A total of 40 guests attended the opening. The new production facility contains a dedicated Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin® for upcoming preclinical and clinical studies. Jan A. Alfheim, Oncoinvent’s CEO commented: “This event marks a highlight in a year that has seen tremendous growth in the company.